NOVALIX BELGIUM

Braine-l'Alleud ·KBO/BCE: BE 0784.616.271

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-08-2025	30 d late	2025-00447752
31-12-2023	31-07-2024	12-12-2024	134 d late	2024-00614534
31-12-2022	31-07-2023	27-07-2023	4 d early	2023-00275452

Metric	This company	Sector median	Position in the sector
Solvency	-4.1%	53.6%	better than 13% of 42 sector peers
Net result	€-58k	€-16k	better than 45% of 41 sector peers
Equity	€-44k	€644k	better than 9% of 42 sector peers
Gross operating margin	€2.79M	€7k	better than 95% of 33 sector peers
Total assets	€1.08M	€1.71M	better than 41% of 42 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.08M
Fixed assets	21/28	€2k
Financial fixed assets	28	€2k
Current assets	29/58	€1.08M
Amounts receivable within one year	40/41	€402k
Cash & bank	54/58	€679k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.08M
Equity	10/15	€-44k
Contributions / capital	10/11	€10k
Accumulated profits (losses)	14	€-54k
Amounts payable	17/49	€1.13M
Amounts payable within one year	42/48	€1.13M
Trade debts payable within one year	44	€613k
Income statement
Gross operating margin	9900	€2.79M
Operating result	9901	€23k
Financial income	75	€80
Financial charges	65	€69k
Result before taxes	9903	€-46k
Income taxes	67/77	€12k
Net result for the period	9904	€-58k
Result to be appropriated	9905	€-58k

Summary

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Private limited company(610)
Incorporation	07-04-2022
Status	Active
Postal code	1420